Time to First Occurrence of Treatment Failure (ITT Population- All Patients).
Reprinted from the Journal of Vascular Surgery, Vol. 54, Issue 4, Pages 1032–1041, Powell RJ et al, Interim analysis results from the RESTORE-CLI, a randomized, double-blind, multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia, Copyright 2011, with permission from Elsevier.